206 results on '"Krishnatry, R"'
Search Results
2. High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system
3. Impact of Adjuvant Treatment in pN3 Penile Cancer
4. Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach
5. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
6. Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer
7. Prospective Longitudinal Assessment of Quality of Life and Activities of Daily Living as Patient-Reported Outcome Measures in Recurrent/Progressive Glioma Treated with High-dose Salvage Re-irradiation
8. Dose Escalation Using Magnetic Resonance Guided High-Dose-Rate Endorectal Brachytherapy to Enhance Clinical Response after Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
9. Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation
10. An Audit for Radiotherapy Planning and Treatment Errors From a Low–Middle-Income Country Centre
11. Early Results of Extreme Hypofractionation Using Stereotactic Body Radiation Therapy for High-risk, Very High-risk and Node-positive Prostate Cancer
12. PO-1395 SIB-IMRT boost during SCRT and chemotherapy for locally advanced rectal cancer
13. PO-2340 The emerging role of radiation therapists in contouring organs at risk for rectal cancer.
14. Reduction of Tumor Length by >50%, Post Neoadjuvant Chemoradiation as a Predictor for Complete Response and Organ Preservation in Rectal Cancer
15. P-255 Outcome of local radiation therapy in oligo-recurrent biliary tract cancers
16. P-201 Using SBRT in treating oligorecurrences of carcinoma of stomach
17. PO-1282 Local control still a challenge in post-SBRT advanced Pancreatic cancer - A single institute series
18. Stereotactic Conformal Radiotherapy in Non-small Cell Lung Cancer — An Overview
19. PD-0852 Recommendations and clinical validation of inguinal CTV delineation in penile cancer
20. OC-0613: Prostate Only or Pelvic Radiotherapy in High Risk Prostate Cancer: Outcomes of a Randomised Trial
21. PO-139: Cushing’s disease outcomes with conventional fractionated modern stereotactic conformal or IM-IGRT
22. Combination of urinary symptoms & cytology can decrease the need of cystoscopies at regular follow-up assessments for post triple modality bladder preservation treatment in MIBC
23. Optimizing Immobilization and IGRT schedule for decreasing PTV margins for supine Cranio-spinal irradiation
24. Pattern of care in high-grade gliomas after recurrence
25. Institutional experience of re-RT in Diffuse Intrinsic Pontine Glioma
26. Multidisciplinary brain metastasis clinic: Is it effective and worthwhile?
27. PV-0629 Late toxicity and PROMs in pelvic or prostate RT in high risk prostate cancer: A randomized trial.
28. PO-0863 Adaptive radiotherapy for carcinoma of the urinary bladder: Long term outcomes with dose escalation
29. EP-1235 Response to re-RT helps deciding dose and predicts survival in Diffuse Intrinsic Pontine Glioma
30. EP-1586 FDG PET-CT based risk-adapted radiotherapy for post-chemotherapy residual mass in advanced seminoma
31. Survey on Adaptive Radiotherapy Practice
32. Adaptive radiotherapy for carcinoma of the urinary bladder: Long term outcomes with dose escalation
33. P05.13 Long term clinical outcomes with helical tomotherapy based image guided intensity modulated radiotherapy for benign and low grade brain tumours
34. Factors predicting 'time to distant metastasis' in radically treated head and neck cancer
35. PO-0712: Radiomics to predict medulloblastomas molecular subgroups: prospective blinded data of 111 patients
36. Ga-68 PSMA PETCT response to androgen deprivation therapy in patients with prostate cancer
37. 57P - Multidisciplinary brain metastasis clinic: Is it effective and worthwhile?
38. 59P - Pattern of care in high-grade gliomas after recurrence
39. P143 - Combination of urinary symptoms & cytology can decrease the need of cystoscopies at regular follow-up assessments for post triple modality bladder preservation treatment in MIBC
40. OS02.3 Need for reclassifying treatment strategies for different subgroups of SHH medulloblastoma, paediatric and adult SHH-MB fail deferentially
41. P09.03 Bevacizumab in glioma: An experience from Tata Memorial Hospital
42. EO3 - Ga-68 PSMA PETCT response to androgen deprivation therapy in patients with prostate cancer
43. OT-05 * H3.3-K27M IS A NEGATIVE PROGNOSTIC MARKER IN THALAMIC PEDIATRIC GLIOMA
44. LG-03 * RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY
45. LG-01 * BRAF MUTATION AND CDKN2A DELETION DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH-GRADE GLIOMA
46. PT-01 * THE IMPACT OF INITIAL RADIATION IN INFANTS AND THE RE-IRRADIATION OF RECURRENT DISEASE ON THE SURVIVAL OF EPENDYMOMA PATIENTS AT THE HOSPITAL FOR SICK CHILDREN, TORONTO
47. BI-21 * BRAF MUTATION AND CDKN2A DELETIONS DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH GRADE GLIOMA
48. The impact of initial radiation in infants and the re-irradiation of recurrent disease on the survival of ependymoma patients at The Hospital for Sick Children, Toronto
49. EPENDYMOMA
50. Factors predicting ′time to distant metastasis′ in radically treated head and neck cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.